Analyst firms · BofA Securities · QRVO
BofA Securities QRVO price target and rating history
Qorvo Inc. (QRVO) · Technology
BofA Securities rates Qorvo Inc. (QRVO) Underperform with a $95 price target, as of its latest action on Jun 29, 2022. It has published 4 rating actions on QRVO since November 2021, including 0 upgrades and 2 downgrades. Across 4 firms with a QRVO price target in the last 12 months, the median target is $87.50.
- Current rating
- Underperform
- Price target
- $95
- Median target, all firms
- $87.50
- Actions on QRVO
- 4
BofA Securities price target on QRVO
Every BofA Securities rating on QRVO
- Jun 29, 2022
- Feb 3, 2022
- Jan 10, 2022
- Nov 4, 2021
How other firms rate QRVO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Overweight | $100 | Apr 22, 2026 |
| Mizuho | Underperform | $66 | Apr 20, 2026 |
| Wolfe Research | Peer Perform | Apr 17, 2026 | |
| Craig-Hallum | Buy | $95 | Jan 28, 2026 |
| TD Cowen | Hold | $80 | Jan 28, 2026 |
Questions about BofA Securities and QRVO
- What is BofA Securities's price target for QRVO?
- BofA Securities's latest stated price target for Qorvo Inc. (QRVO) is $95, from its action on Jun 29, 2022.
- What is BofA Securities's rating on QRVO?
- BofA Securities rates QRVO Underperform, a bearish rating, as of Jun 29, 2022.
- When did BofA Securities last change its view on QRVO?
- On Jun 29, 2022, BofA Securities downgrades to Underperform from Neutral, price target $125 to $95.
- How does BofA Securities's QRVO target compare with other analysts?
- Across 4 firms with a QRVO price target in the last 12 months, the median target is $87.50.
More QRVO rating histories
- Barclays4
- Mizuho6
- Craig-Hallum3
- TD Cowen8
- Morgan Stanley8
- The Benchmark Company6
- Piper Sandler3
- Raymond James3
- BNP Paribas Exane3
- Summit Insights4
- Rosenblatt3
- Oppenheimer3
All BofA Securities ratingsQRVO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.